# TransMedics Group, Inc. (TMDX) FY2026 Q2 P&L / Income Statement

- Company: TransMedics Group, Inc. (TMDX)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-04, accession number 0001193125-26-332843
- Page: https://plicit.ai/financials/tmdx/fy2026-q2-income-statement
- Chart image: https://plicit.ai/charts/tmdx-fy2026-q2-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2026-04-01 through 2026-06-30. View: Product and service. Revenue and costs use their disclosed categories.

- **Total revenue**: 189,948,000 US dollars
- **Total cost of revenue**: 76,750,000 US dollars
- **Gross profit**: 113,198,000 US dollars
- **Total operating expenses**: 89,462,000 US dollars
- **Income from operations**: 23,736,000 US dollars
- **Total other expense, net**: negative 4,331,000 US dollars
- **Income before income taxes**: 19,405,000 US dollars
- **Provision for income taxes**: 4,723,000 US dollars
- **Net income**: 14,682,000 US dollars
- **Net product revenue revenue**: 111,158,000 US dollars
- **Service Revenue revenue**: 78,790,000 US dollars
- **Net product revenue cost of revenue**: 25,566,000 US dollars
- **Service Revenue cost of revenue**: 51,184,000 US dollars
- **Research, development and clinical trials**: 31,632,000 US dollars
- **Selling, general and administrative**: 57,830,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Business Segment by Geography

- Page: https://plicit.ai/financials/tmdx/fy2026-q2-income-statement/revenue-by-business-segment-by-geography
- Chart image: https://plicit.ai/charts/tmdx-fy2026-q2-revenue-by-business-segment-by-geography-sankey.png

Income statement for 2026-04-01 through 2026-06-30. View: Segments by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenue**: 189,948,000 US dollars
- **Total cost of revenue**: 76,750,000 US dollars
- **Gross profit**: 113,198,000 US dollars
- **Total operating expenses**: 89,462,000 US dollars
- **Income from operations**: 23,736,000 US dollars
- **Total other expense, net**: negative 4,331,000 US dollars
- **Income before income taxes**: 19,405,000 US dollars
- **Provision for income taxes**: 4,723,000 US dollars
- **Net income**: 14,682,000 US dollars
- **OCS transplant revenue - UNITED STATES**: 183,623,000 US dollars
- **OCS transplant revenue - All Other Countries**: 5,241,000 US dollars
- **Undisclosed (calculated)**: 1,084,000 US dollars
- **Research, development and clinical trials**: 31,632,000 US dollars
- **Selling, general and administrative**: 57,830,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.